About Landing Med
Founded in 2000, Landing Med is a medical technology company focused on digital pathology solutions. Our mission is to reduce cancer-related mortalities and to help pathologists increase diagnostic efficiency, confidence and accuracy. Our versatile, robust and accessible digital solutions enable labs of all sizes to improve performance. Since our founding, we have accumulated more than 10 million samples and led multiple population-based AI-assisted cervical cancer screening programs across China.
Landing Med Completes 1 Million Cervical Cancer Screenings in 50 Days
By automating the most labor intensive parts of the cervical cancer screening process with robots and an AI cloud platform, Landing Med’s central lab can screen up to 20,000 samples/day.